Bio-Rad Laboratories, Inc. Class B(BIO.B)
$367.98-10.52 (-2.78%)
BIO.B
Bio-Rad Laboratories, Inc. Class B earnings date
$367.98
At close:-10.52 (-2.78%)
Want to see BIO.B full AI Analyst Report?
Bio-Rad Laboratories, Inc. Class B (BIO.B) Q2 2025 Earnings Report
1 Followers
BIO.B Q2 2025 EPS Results
- Actual EPS
- $2.61
- Consensus EPS
- $1.75
- Beat/Miss
- Beat by +$0.86
- One Year Ago EPS
- $3.11
BIO.B Q2 2025 Revenue Results
- Actual Revenue
- $651.60M
- Expected Revenue
- $615.02M
- Beat/Miss
- Beat by +$36.58M
- YoY Revenue Growth
- +2.06%
Earnings Announcement Details
- Quarter
- Q2 2025
- Date
- 07/31/2025
- Time
- After Close
- Conference Call
- Thursday, July 31, 2025
BIO.B Upcoming Earnings
Bio-Rad Laboratories, Inc. Class B's next earnings date is estimated for February 18, 2027, based on past reporting schedules.
Q2 2025 Earnings Call Audio
No earnings call audio is available for this earnings event.
Q2 2025 Earnings Slide Deck
No slide deck is available for this earnings event.
Q2 2025 Earnings Call Summary
No earnings call summary is available for this earnings event.
BIO.B Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release |
|---|---|---|---|---|---|
| Feb 18, 2027 | 2026 (Q4) | 2.83- | 2.51 | ― | ― |
| Nov 04, 2026 | 2026 (Q3) | 2.232.65 | 2.26 | 17.26% (+0.39) | |
| Aug 04, 2026 | 2026 (Q2) | 1.782.62 | 2.61 | 0.38% (+0.01) | |
| Apr 30, 2026 | 2026 (Q1) | 2.011.89 | 2.54 | -25.59% (-0.65) | |
| Feb 12, 2026 | 2025 (Q4) | 2.692.51 | 2.9 | -13.45% (-0.39) | |
| Oct 29, 2025 | 2025 (Q3) | 1.892.26 | 2.01 | 12.44% (+0.25) | |
| Jul 31, 2025 | 2025 (Q2) | 1.752.61 | 3.11 | -16.08% (-0.50) | |
| May 01, 2025 | 2025 (Q1) | 1.822.54 | 2.29 | 10.92% (+0.25) | |
| Feb 13, 2025 | 2024 (Q4) | 2.862.90 | 3.1 | -6.45% (-0.20) | |
| Oct 30, 2024 | 2024 (Q3) | 1.132.01 | 2.33 | -13.73% (-0.32) |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat Missed

